Spatial transcriptomics analysis of urticarial rash skin from patients with Schnitzler syndrome

ABSTRACT: We conducted a multicenter, open-label, single-arm phase II trial (SCan Study) to evaluate the efficacy and safety of canakinumab in 5 Japanese patients with Schnitzler syndrome (SchS), based on a similar study conducted in Germany. As part of this study, spatial transcriptomics of urticarial rash skin lesions were performed before treatment in 2 cases to identify IL1B-expressing cells. The spatial transcriptomics analysis was conducted using the 10x Genomics Xenium platform.

ORGANISM(S): Homo sapiens

PROVIDER: GSE292123 | GEO | 2025/04/21

REPOSITORIES: GEO